Presentation TCT 2017 Intracoronary Pharmacology: Approach to Thrombus and the Prevention and Treatment of No Reflow Presenter: David P. Faxon, Robert S. Schwartz, Raffaele Piccolo October 31, 2017
Presentation TCT 2017 Coronary Flow, Collateral Flow, and Fractional Flow Reserve in Culprit and Nonculprit Lesions in STEMI Presenter: David P. Faxon, Robert S. Schwartz, Matthias Götberg October 31, 2017
Presentation TCT 2017 Case #3: Recanalization of a CTO Presenter: João AB Brum Silveira, Marcelo Jose de Carvalho Cantarelli, Alexandre Schaan Quadros October 31, 2017
Presentation TCT 2017 Recognition, Diagnosis, and Management of Spontaneous Coronary Artery Dissection Presenter: David P. Faxon, Robert S. Schwartz, Jacqueline Saw October 31, 2017
Presentation TCT 2017 Case #2: Double Aortic and Mitral Transcatheter Valve Replacement Using Innovative Bioprostheses Presenter: João AB Brum Silveira, Marcelo Jose de Carvalho Cantarelli, Henrique B. Ribeiro October 31, 2017
Presentation TCT 2017 Bioresorbable Scaffolds One Year After Approval: FDA Perspectives on Current and Future BRS Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Andrew Farb October 31, 2017
Presentation TCT 2017 Bioresorbable Scaffolds One Year After Approval: Physician-scientist Perspectives on Current and Future BRS Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Gregg W. Stone October 31, 2017
Presentation TCT 2017 Case #1: Fatal Embolization During Left Atrial Appendage Percutaneous Occlusion in a TAVR Patient Presenter: João AB Brum Silveira, Marcelo Jose de Carvalho Cantarelli, Antonio Fiarresga October 31, 2017
Presentation TCT 2017 TCT 31: Hybrid iFR-FFR Decision-Making Strategy in Coronary Revascularization of Patients With Severe Aortic Stenosis Undergoing TAVI Presenter: Justin E. Davies, Bernard De Bruyne, Gabriele Pesarini, MD October 31, 2017
Presentation TCT 2017 FDA Perspectives on Short DAPT IDE Trials Presenter: Mitchell W. Krucoff, P.F. Adrian Magee October 31, 2017
Presentation TCT 2017 The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Standard vs Novel DES and DAPT Duration Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Ajay J. Kirtane October 31, 2017
Presentation TCT 2017 The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Appropriate Patients and DAPT Duration Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Marie-Claude Morice October 31, 2017
Presentation TCT 2017 DCB Preclinical Perspectives: Mechanisms and Experimental Safety and Efficacy of Older, Current, and Futuristic DCB Presenter: Robert A. Byrne, Ran Kornowski, Juan F. Granada October 30, 2017
Presentation TCT 2017 Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy Presenter: Robert A. Byrne, Ran Kornowski, Ron Waksman October 30, 2017
Presentation TCT 2017 Treatment of First-time In-Stent Restenosis State-of-the-Art Review: From Lesion Preparation and Imaging to Restenting to DCB Presenter: Robert A. Byrne, Ran Kornowski, Fernando Alfonso October 30, 2017
Presentation TCT 2017 Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow? Presenter: Robert A. Byrne, Ran Kornowski, Bernardo Cortese October 30, 2017
Presentation TCT 2017 Drug-Coated Coronary Balloon Therapy: Current State-of-the-Art Presenter: Robert A. Byrne, Ran Kornowski, Bruno Scheller October 30, 2017
Presentation TCT 2017 In This Case: Multimodality Physiology and Imaging Coregistration (With Discussion) Presenter: Justin E. Davies, Nils Johnson, Sukhjinder S Nijjer October 30, 2017
Presentation TCT 2017 Slovakia Presents: Case Conclusion - How I Treated This Case Presenter: Petr Kala, Jochen Wöhrle, Petra Poliacikova October 30, 2017
Presentation TCT 2017 Germany Comments: How Would I Treat This Case and Why? Presenter: Petr Kala, Jochen Wöhrle, Thomas Walther October 30, 2017